SMMT logo

Summit Therapeutics PLC (SMMT)

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small l...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
SMMT
ISIN Code
US86627T1088
Currency
US Dollar (USD)
IPO Date
2015-03-05

Contact Information

Company Address
601 Brickell Key Drive, Miami, FL, United States, 33131
Contact Phone
305 203 2034
Company Website
https://www.smmttx.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$705,000
Return on Assets (TTM)
-101.61%
EBITDA
$-999,999.99
Revenue (TTM)
$0